Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Davita Inc.

Davita Inc. (DVA)

Market is closed
News
Xerenex Kidney Treatment: A Game Changer for Keryx Biopharmaceuticals (KERX)

Xerenex Kidney Treatment: A Game Changer for Keryx Biopharmaceuticals (KERX)

Keryx Biopharmaceuticals (NASDAQ:KERX)’s latest kidney drug called Zerenex is a game changer for the company after achieving positive results from its long-term Phase 3 study, which is the second and...

Keep Reading →

February 11th, 2013 - News

Hedge Fund News: David Tepper, Steve Cohen, CVR Refining LP (CVRR)

Hedge Fund News: David Tepper, Steve Cohen, CVR Refining LP (CVRR)

David Tepper, the hedge-fund manager who runs the $15 billion Appaloosa Management LP, said he’s bullish on U.S. stocks as the economy is set to grow by as much as 3 percent this year.

Keep Reading →

January 23rd, 2013 - Hedge Funds

What's Next for Affymax, Inc. (AFFY)?

What's Next for Affymax, Inc. (AFFY)?

Affymax, Inc. (NASDAQ:AFFY) received its first Food and Drug Administration approval last spring with Omontys for anemia in dialysis patients. The drug enters a war against Amgen, Inc.

Keep Reading →

January 22nd, 2013 - News

Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)